Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Zachariah DeFilipp

Showing results (131-140 of 141) with videos related to

Pageof 15
Sort By:
Blood Advances|May 3, 2023
A simple prognostic system in patients with myelofibrosis undergoing allogeneic stem cell transplantation: a CIBMTR/EBMT analysisRoni Tamari, Donal P McLornan, Kwang Woo Ahn, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 5, 2020
Composite GRFS and CRFS Outcomes After Adult Alternative Donor HCTRohtesh S Mehta, Shernan G Holtan, Tao Wang, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|October 6, 2018
Characteristics of Late Fatal Infections after Allogeneic Hematopoietic Cell TransplantationMaxim Norkin, Bronwen E Shaw, Ruta Brazauskas, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|August 12, 2020
A Personalized Prediction Model for Outcomes after Allogeneic Hematopoietic Cell Transplant in Patients with Myelodysplastic SyndromesAziz Nazha, Zhen-Huan Hu, Tao Wang, et al.
Bone Marrow Transplantation|September 29, 2021
An adapted European LeukemiaNet genetic risk stratification for acute myeloid leukemia patients undergoing allogeneic hematopoietic cell transplant. A CIBMTR analysisAntonio M Jimenez Jimenez, Marcos De Lima, Krishna V Komanduri, et al.
Transplantation and Cellular Therapy|July 26, 2021
Standardizing Definitions of Hematopoietic Recovery, Graft Rejection, Graft Failure, Poor Graft Function, and Donor Chimerism in Allogeneic Hematopoietic Cell Transplantation: A Report on Behalf of the American Society for Transplantation and Cellular TherapyMohamed A Kharfan-Dabaja, Ambuj Kumar, Ernesto Ayala, et al.
Bone Marrow Transplantation|April 17, 2021
Impact of depth of clinical response on outcomes of acute myeloid leukemia patients in first complete remission who undergo allogeneic hematopoietic cell transplantationMary-Elizabeth Percival, Hai-Lin Wang, Mei-Jie Zhang, et al.
Blood Advances|June 25, 2024
Donor types and outcomes of transplantation in myelofibrosis: a CIBMTR studyTania Jain, Noel Estrada-Merly, M Queralt Salas, et al.
Leukemia Research|July 30, 2018
Risk of acute myeloid leukemia and myelodysplastic syndrome after autotransplants for lymphomas and plasma cell myelomaTomas Radivoyevitch, Robert M Dean, Bronwen E Shaw, et al.
Blood Advances|May 9, 2020
Survival following allogeneic transplant in patients with myelofibrosisKrisstina Gowin, Karen Ballen, Kwang Woo Ahn, et al.
Pageof 15

Showing results (131-140 of 141) with videos related to

Sort By:
Pageof 15
Blood Advances|May 3, 2023
A simple prognostic system in patients with myelofibrosis undergoing allogeneic stem cell transplantation: a CIBMTR/EBMT analysisRoni Tamari, Donal P McLornan, Kwang Woo Ahn, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 5, 2020
Composite GRFS and CRFS Outcomes After Adult Alternative Donor HCTRohtesh S Mehta, Shernan G Holtan, Tao Wang, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|October 6, 2018
Characteristics of Late Fatal Infections after Allogeneic Hematopoietic Cell TransplantationMaxim Norkin, Bronwen E Shaw, Ruta Brazauskas, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|August 12, 2020
A Personalized Prediction Model for Outcomes after Allogeneic Hematopoietic Cell Transplant in Patients with Myelodysplastic SyndromesAziz Nazha, Zhen-Huan Hu, Tao Wang, et al.
Bone Marrow Transplantation|September 29, 2021
An adapted European LeukemiaNet genetic risk stratification for acute myeloid leukemia patients undergoing allogeneic hematopoietic cell transplant. A CIBMTR analysisAntonio M Jimenez Jimenez, Marcos De Lima, Krishna V Komanduri, et al.
Transplantation and Cellular Therapy|July 26, 2021
Standardizing Definitions of Hematopoietic Recovery, Graft Rejection, Graft Failure, Poor Graft Function, and Donor Chimerism in Allogeneic Hematopoietic Cell Transplantation: A Report on Behalf of the American Society for Transplantation and Cellular TherapyMohamed A Kharfan-Dabaja, Ambuj Kumar, Ernesto Ayala, et al.
Bone Marrow Transplantation|April 17, 2021
Impact of depth of clinical response on outcomes of acute myeloid leukemia patients in first complete remission who undergo allogeneic hematopoietic cell transplantationMary-Elizabeth Percival, Hai-Lin Wang, Mei-Jie Zhang, et al.
Blood Advances|June 25, 2024
Donor types and outcomes of transplantation in myelofibrosis: a CIBMTR studyTania Jain, Noel Estrada-Merly, M Queralt Salas, et al.
Leukemia Research|July 30, 2018
Risk of acute myeloid leukemia and myelodysplastic syndrome after autotransplants for lymphomas and plasma cell myelomaTomas Radivoyevitch, Robert M Dean, Bronwen E Shaw, et al.
Blood Advances|May 9, 2020
Survival following allogeneic transplant in patients with myelofibrosisKrisstina Gowin, Karen Ballen, Kwang Woo Ahn, et al.
Pageof 15